'Best Fit' Communication Strategy Launched by SAFC Biosciences |
 |
September 17, 2007 |
|
|
| |
|
Lenexa, KS - September 17, 2007 - Critical Raw Material supplier to the Biopharm Industry, SAFC Biosciences, a member of the Sigma-Aldrich Group (Nasdaq: SIAL), has revealed a global communications strategy to individually address each of its customer groups' needs at every level and position the business as one exclusively focused on therapeutic cell culture.
Key elements of the new approach include an innovative 'Capabilities Cube'- designed to clearly present SAFC Biosciences' levels of service and solutions at every stage of the clinical pipeline- and an enhanced, customer focused marketing organization headed by new Director of Marketing, Bruce Lehr.
A graphic representation of the SAFC Biosciences business, the interactive, multi-tiered Cube can be accessed at www.safcbiosciences.com. It is split into five levels of knowledge- Research, Process Development, Materials Management, Quality Assurance and Manufacturing. Clicking on any of these tiers highlights SAFC Biosciences' specific expertise in this area and allows the user to look up the precise capabilities relevant to their job function.
Bruce Lehr comments,
'The cube is a pioneering tool with which we can more clearly present the complexities of our product offering and our ability to satisfy customer needs in numerous aspects of their businesses. Combined with the restructuring of our marketing, technical and sales functions, the Cube permits us to tailor our message individually to the various customer groups that we serve.'
Archie Cullen, SAFC Biosciences Vice President, Sales and Marketing adds,
'SAFC Biosciences' internal marketing structure now explicitly reflects the process that our customers follow to commercialize their products. Bruce will spearhead our strategy to customize capability solutions for 'best fit' with our customers' organizational structures and processes. Our marketing efforts are underpinned by the broad product capabilities and expertise possessed within the SAFC organisation.'
Involved with cell culture since the late-1980s, Bruce Lehr has held key management positions in SAFC Biosciences' commercial and technical teams over a number of years. These have included responsibility across the range of product management, R&D, marketing and technical sales. He holds advanced professional degrees in Microbiology and Immunology, and in Business Administration.
A key figure in SAFC Biosciences' Sales & Marketing activity will be Technical Marketing Manager, Denise DeTommaso, who will head the full 'in-field' technical team.
In further changes, Michael James has been appointed as Marketing Manager, Process Development, Jeff Davis as Marketing Manager, Manufacturing and Steve Profitt as European Marketing Manager.
About SAFC Biosciences:
SAFC Biosciences provides an integrated services package in mammalian cell culture media development to support customer programmes from pre-clinical and clinical development to commercialization.
Headquartered in Lenexa, Kansas USA, SAFC Biosciences has six production facilities in the US, Europe and Australia, and employs 600 people. Main product lines include serum-free media, serum-based products, growth factors and disposable bioprocessing systems.
About SAFC: SAFC® is the custom manufacturing and services group within Sigma-Aldrich that
focuses on high-purity inorganics for high technology applications, cell culture products and services for biopharmaceutical manufacturing, biochemical production and the manufacturing of complex, multi-step organic synthesis of APIs and key intermediates. SAFC has manufacturing facilities around the world dedicated to providing manufacturing services for companies requiring a reliable partner to produce their custom manufactured materials. SAFC has four operating segments – SAFC Pharma™, SAFC Supply Solutions™, SAFC Biosciences™, and SAFC Hitech™ – and had annual sales of nearly $500 million in 2006. SAFC is one of the world's 10 largest fine chemicals businesses.
About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high technology manufacturing. We have customers in life science companies, university and government institutions, hospitals and in industry. Over one million scientists and technologists use our products. Sigma-Aldrich operates in 36 countries and has 7,700 employees providing excellent service worldwide. We are committed to accelerating Customers' success through leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit our award-winning web site at sigma-aldrich.com.
Cautionary Statement: This release contains forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs and other statements regarding the Company's expectations, goals, beliefs, intentions and the like, which involve assumptions regarding the Company’s operations and conditions in the markets the Company serves. The Company does not undertake any obligation to update these forward-looking statements.
SAFC® is a registered trademark of Sigma-Aldrich Biotechnology L.P.
Forward Inquiries To:
Bruce Lehr
Director of Marketing
SAFC Biosciences
+ (913).227.6790 |
Media Inquiries:
Mr. Richard Kerns
Northern Exposure
+44.161.728.5880 |
|
| |
|
|
